Among patients with no history of cancer, the tool achieved a prediction accuracy rate of 50%.

A new study suggests that artificial intelligence, also known as AI, may offer a better solution. Scientists have developed a ...

Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA) De Novo authorization for CLAIRITY BREAST, a novel, ...

Despite major advances in genetic testing for breast cancer risk prediction, death rates remain disproportionately high among women of African ancestry. This is often due to a combination of factors, ...

The intersection of artificial intelligence (AI) and healthcare presents a transformative frontier, particularly in the global fight against cancer. As healthcare systems worldwide grapple with rising ...

Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA) De Novo authorization for CLAIRITY BREAST, a novel, ...

New AI-driven systems for detecting and predicting gastrointestinal cancers have been developed through research projects in Singapore and South Korea. A research team from Singapore General Hospital ...

Low-dose computed tomography (LDCT) screening is effective in reducing lung cancer mortality by detecting the disease at earlier, more treatable stages. However, high false-positive rates and the ...

CLAIRITY BREAST provides clinicians with a first-in-class, novel platform for identifying future risk of breast cancer CLAIRITY BREAST analyzes subtle imaging features on screening mammograms that ...